FGAs and SGAs for Managing Explosive Behavior

<p>In this episode, we discuss the SGAs with the most evidence for explosive behavior, their side effects, and monitoring recommendations. We also address the reasons for considering other SGAs and clarify which FGA has the most evidence for aggression.</p> <p>Faculty: Carrie Vaudreuil, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC213" target="_blank" rel="noopener"><strong>Learn more about our memberships here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/managing-explosive-behavior-in-children-and-adolescents-2641?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC213" target="_blank" rel="noopener"><strong>Earn 0.75 CME: Managing Explosive Behavior in Children and Adolescents</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/first-and-second-generation-antipsychotics-for-managing-explosive-behavior-2641-5222?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC213" target="_blank" rel="noopener"><strong>First- and Second-Generation Antipsychotics for Managing Explosive Behavior</strong></a></li> </ul>